(Q40217897)

English

T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates

scientific article published on 18 October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

viral quasispecies

1 reference

based on heuristic

inferred from title

Hanneke Schuitemaker

7

object named as

Hanneke Schuitemaker

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Angélique B van 't Wout

6

object named as

Angélique B van 't Wout

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

author name string

Esther D Quakkelaar

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Tim Beaumont

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Ad C van Nuenen

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Floris P J van Alphen

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Brigitte D M Boeser-Nunnink

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

language of work or name

0 references

publication date

18 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

359

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

92-104

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Increased sensitivity to CD4 binding site-directed neutralization following in vitro propagation on primary lymphocytes of a neutralization-resistant human immunodeficiency virus IIIB strain isolated from an accidentally infected laboratory worker

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Dating of the human-ape splitting by a molecular clock of mitochondrial DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Molecular cloning and characterization of a German HIV-1 isolate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24gag

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Position and degree of mismatches and the mobility of DNA heteroduplexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Antibody neutralization and escape by HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

DAMBE: software package for data analysis in molecular biology and evolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

Rapid and simple method for purification of nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

based on heuristic

inferred from DOI database lookup

Equal levels of gp120 retention and neutralization resistance of phenotypically distinct primary human immunodeficiency virus type 1 variants upon soluble CD4 treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

based on heuristic

inferred from DOI database lookup

Change in tropism upon immune escape by human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

based on heuristic

inferred from DOI database lookup

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.021

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2006.09.021

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40217897&oldid=2196098521"